CD79A and neoplasm: While the implications of these findings need to be explored further, tumor-infiltrating IgA+ B cells, as opposed to IgG+ B cells, have been shown to contribute to a microenvironment that downregulates immune responses to tumors.61 It is possible that the presence of IgA+ cells in accepted kidney allografts serves a similarly protective function.